Sintx Technologies SINT

NASDAQ SINT
$1.59 -0.03 (-1.85%)
At close: Aug 19, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap7.83 Mn
P/E-0.51
P/S7.57
Div. Yield0.00
Add ratio to table…

About

SINTX Technologies develops, manufactures, and commercializes silicon nitride biomaterials, composites, and devices for medical and other high-value applications. The company is an advanced ceramics company founded in December 1996 and focuses on medical grade silicon nitride for musculoskeletal and antipathogenic uses. It also supplies silicon nitride parts to customers in the electrical, aerospace, and industrial sectors. SINTX operates its own manufacturing facility in…

Read more ↓
Sectors: Healthcare · Industrials Sector rationale The company's primary business is the development and manufacture of medical-grade silicon nitride for musculoskeletal and antipathogenic uses, selling spinal fusion implants and osteotomy wedges to hospitals and surgical centers. A secondary sector is justified because the company also maintains a distinct business line supplying silicon nitride parts to original equipment manufacturers (OEMs) in the aerospace, electrical, and industrial sectors. Industries: Medical Devices Healthcare Primary SINTX designs and manufactures therapeutic medical devices, specifically interbody spinal fusion implants and foot and ankle osteotomy wedges. These products are sold directly to hospitals and surgical centers or through OEM partnerships. Metal Fabrication Industrials Secondary The company manufactures and supplies silicon nitride parts and components to original equipment manufacturers (OEMs) in the electrical, aerospace, and industrial sectors. Medical Supplies Healthcare Secondary SINTX develops and sells antipathogenic powders and coatings intended for use in wound care devices, which falls under medical supplies and consumables. Classified using BQ-MICS CIK: 0001269026

Product and Service Breakdown of Revenue (2025)

Peer Comparison

Companies in the Medical Devices
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 ABT Abbott Laboratories 196.58 Bn36.244.2232.61 Bn
2 SYK Stryker Corp 127.35 Bn34.154.9314.94 Bn
3 MDT Medtronic plc 118.25 Bn24.443.2527.96 Bn
4 BSX Boston Scientific Corp 74.32 Bn20.223.5412.62 Bn
5 EW Edwards Lifesciences Corp 52.61 Bn2,104.558.080.60 Bn
6 DXCM Dexcom Inc 34.26 Bn34.276.90-
7 GEHC GE HealthCare Technologies Inc. 32.92 Bn16.051.5510.10 Bn
8 SNN Smith & Nephew Plc 26.16 Bn156.664.313.21 Bn